发明名称 ION BINDING COMPOSITION
摘要 <P>PROBLEM TO BE SOLVED: To provide a safe and high capacity binder which selectively remove ions from the body with a lower drug dosage and a better patient compliance profile. <P>SOLUTION: There is provided a pharmaceutical composition comprising core-shell particles. In the pharmaceutical composition, the core-shell particles comprise a core component and a shell component and the core-shell particles in the animal subject are connected to the larger amount of inorganic ions in the presence of the shell component compared with the amount of those in the absence of the shell component and the inorganic ions are negative ions. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012031210(A) 申请公布日期 2012.02.16
申请号 JP20110246755 申请日期 2011.11.10
申请人 ILYPSA INC 发明人 CHARMOT DOMINIQUE;FORDTRAN JOHN;CHANG HAN TING;CONNOR ERIC;LIU MINGJUN;KEAERNER GERRIT
分类号 A61K9/14;A61K9/16;A61K9/32;A61K9/50;A61K31/74;A61K45/06;A61K47/30;A61K47/32;A61K47/34;A61K47/38;A61P1/16;A61P3/00;A61P3/12;A61P7/00;A61P9/04;A61P9/12;A61P13/12;A61P39/02 主分类号 A61K9/14
代理机构 代理人
主权项
地址